Skip to main content

Table 1 Individual and Overall

From: Dose distribution in the thyroid gland following radiation therapy of breast cancer-a retrospective study

Characteristic

Cases

Controls

Age1(yrs)

  

< 50

3

3

> 50

13

13

Median

56

56

Range

44-75

43-73

Obstime 2 (months)

  

< 50

11

12

≥ 50

5

4

Median

44

44

Range

38-56

37-56

Stage

  

II

13

13

III

3

3

Surgery 3

  

MRM

12

12

BCS

4

4

Chemo 4

  

FEC

11

11

other

1

1

No

4

4

Number of Cycles

  

6

11

11

4

1

1

Tamoxifen

  

yes

15

15

No

1

1

RT (Gy)

  

50 Gy

13

13

50+10 Gy

3

3

  1. Radiotherapy, surgical and chemotherapy treatment characteristics for cases (group A) and controls (group B).
  2. 1Age: Age at follow-up
  3. 2Obstime: observation time from breast cancer diagnosis to the outpatient examination
  4. 3Surgery: MRM = Radical mastectomy, BCS = breast conserving surgery
  5. 4Chemotherapy: FEC = (5Fluoro-Uracil, epirubicin, cyclophosfamide), FEC- regimen
  6. Other = 4 cycles of epirubicin
  7. No = no chemotherapy
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us